GREENVILLE, S.C., June 27, 2025 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NYSE: UCB) announces it will release its second quarter 2025 financial results on Wednesday, July 23, 2025, before the stock market opens. The company also will hold a conference call at 9:00 a.m. EST on Wednesday, July 23, 2025, to discuss its financial results, business highlights, and outlook. Participants can pre-register for the conference call by navigating to https://dpregister.com/sreg/10200766/ff6c2759d0. Those withou ...

Hapbee Expands Board by Three Members with Senior Leaders in Tech, Legal, and Finance as it Enters Next Phase of Growth; Announces Revocation of MCTOMONTREAL, June 27, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies Inc. (TSXV: HAPB), the digital wellness company behind the pioneering bio-streaming wearable platform, today announced the appointment of Ahsan Ashraf to its Board of Directors. Mr. Ashraf, a veteran technologist and product strategist, recently joined the company as Chief Technology Officer and no ...

TORONTO, June 27, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today the voting results from its annual general meeting of shareholders held virtually on June 27, 2025. All director nominees were elected to the Company’s board of directors and MNP LLP was appointed as auditors, as further described in the Company’s management information circular dated May 8, 2025. The summary of the results are as follows: Total Shares Voted: 33,721,314Total Shares ...

TORONTO, June 27, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that it is completing a non-brokered private placement of class A multiple voting shares (“MVS”) at a price of $50 per MVS, for aggregate gross proceeds of up to $600 (the “Offering”). The Company expects that the entirety of the Offering ...

文章核心观点 公司成功完成3.45亿美元可转换优先票据私募发行，通过再融资高成本债务和管理债务到期情况，增强财务灵活性，减少股东潜在摊薄，预计每年节省约900万美元净利息支出并提升自由现金流 [1][2][4] 分组1：发行情况 - 公司完成3.45亿美元2.875%于2031年7月到期的可转换优先票据私募发行，包括此前宣布的3亿美元增额发行及4500万美元额外票据购买权的全额行使 [1] - 票据仅出售给被合理认为是合格机构买家的人士，依据经修订的1933年《证券法》规则144A进行 [1] 分组2：管理层观点 - 首席执行官表示此次成功发行是加强公司资本结构和实现长期增长的重要里程碑，通过再融资和管理债务到期情况增强财务灵活性并减少股东潜在摊薄 [2] - 首席财务官称可转换票据发行需求强劲，使交易增额并优化资产负债表，偿还定期贷款可延长循环信贷额度到期时间，折价回购部分2028年可转换票据为股东创造价值，上限期权交易可防止摊薄 [2] 分组3：资金使用 - 发行净收益约3.341亿美元，公司计划用部分净收益和1210万美元现金全额偿还约2.328亿美元定期贷款未偿债务 [2] - 用约3510万美元净收益进行上限期权交易 [2] - 用部分净收益以约7830万美元现金加应计未付利息回购约1亿美元2028年到期的1.00%可转换优先票据 [2] 分组4：上限期权交易 - 与发行相关的上限期权交易预计可减少票据转换时普通股的潜在摊薄，或抵消公司需支付超过转换票据本金的现金，上限初始为每股12.74美元 [3] - 上限期权初始行权价为每股8.12美元，可调整，对应票据初始转换价格 [3] 分组5：预期效果 - 这些交易预计每年节省约900万美元净利息支出，提升自由现金流 [4] 分组6：公司简介 - 公司是全球领先的太阳能跟踪技术供应商，为公用事业规模和分布式发电客户提供服务，产品可承受恶劣天气，能最大化能源生产并为客户创造价值 [5] - 公司总部设在美国，以制造为基础，依靠国内制造、多元化全球供应链和以客户为中心的方法在全球部署太阳能 [5]

Bexotegrast development in IPF discontinued Clinical oncology program and early-stage programs continue Recent workforce and operational changes align with next steps SOUTH SAN FRANCISCO, Calif., June 27, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that following the review of data from the recently terminated BEACON-IPF Phase 2b/3 clinical trial, the Company has discontinued development of bexotegrast in idiopathic pulmonary fibrosis (IPF). BEACON-IPF Trial Update BEA ...

文章核心观点 - 2025年6月27日SiTime公司宣布完成后续公开发行201.25万股普通股，扣除承销折扣、佣金和估计发行费用后净收益约3.874亿美元 [1] 发行情况 - 公司以每股200美元价格公开发行201.25万股普通股，包括承销商全额行使额外股份购买权 [1] - 扣除承销折扣、佣金和估计发行费用后，公司净收益约3.874亿美元 [1] - UBS Investment Bank和Stifel为联合牵头账簿管理人，Needham & Company和Goldman Sachs & Co. LLC为联合账簿管理人，Raymond James和Roth Capital Partners为副承销商 [2] 注册与文件获取 - 2024年2月26日向美国证券交易委员会提交证券注册声明并于提交时生效，发行通过招股说明书补充文件和随附招股说明书进行 [3] - 可从UBS Securities LLC或Stifel, Nicolaus & Company获取招股说明书补充文件和随附招股说明书，提供了联系地址、电话和邮箱 [3] 公司介绍 - SiTime公司是精密计时公司，其半导体MEMS可编程解决方案功能丰富，能让客户产品在性能、尺寸、功耗和可靠性方面更具差异化，已发货超35亿个设备 [5] 投资者关系联系方式 - Shelton Group的Leanne Sievers和Brett Perry，邮箱sitm - ir@sheltongroup.com [6] - 公司首席财务官Beth Howe，邮箱investor.relations@sitime.com [6]

NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) -- Portman Ridge Finance Corporation (NASDAQ: PTMN) (“Portman Ridge” or “PTMN”) announced today that it obtained shareholder approval for the issuance of PTMN common stock in connection with the proposed merger of Logan Ridge Finance Corporation (NASDAQ: LRFC) (“Logan Ridge” or “LRFC”) with and into PTMN (the “Share Issuance Proposal”) following the adjourned special meeting of shareholders held on June 27, 2025. PTMN shareholders voted overwhelmingly in favor of the ...

NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that, pursuant to a securities purchase agreement (the “Purchase Agreement”) with Blue Harbour Asset Management L.L.C-FZ (“Blue Harbour”), it has completed a private placement of the Company’s newly designated Series C Convertible Preferred Stock (the “Preferred Stock”). Pursuant to the Purchase Agreement, Blue Harbour purchased 60,000 shares of Preferred Stock for an aggregate p ...

BEIJING, June 27, 2025 (GLOBE NEWSWIRE) -- Julong Holding Limited (“Julong” or the “Company”) (Nasdaq: JLHL), a growth-oriented provider of intelligent integrated solutions, today announced the closing of its initial public offering (the “Offering”) of 1,250,000 Class A ordinary shares, at a public offering price of US$4.00 per share (the “Offering Price”). The Company’s Class A ordinary shares began trading on the Nasdaq Capital Market on June 26, 2025, under the ticker symbol “JLHL.” The aggregate gross p ...